
1. bmc infect dis. 2015 nov 11;15:511. doi: 10.1186/s12879-015-1272-6.

performance c-reactive protein procalcitonin distinguish viral from
bacterial malarial causes fever southeast asia.

lubell y(1)(2), blacksell sd(3)(4), dunachie s(5)(6), tanganuchitcharnchai a(7), 
althaus t(8), watthanaworawit w(9)(10), paris dh(11)(12), mayxay m(13)(14)(15),
peto tj(16)(17), dondorp am(18)(19), white nj(20)(21), day np(22)(23), nosten
f(24)(25)(26), newton pn(27)(28), turner p(29)(30)(31).

author information: 
(1)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. yoel@tropmedres.ac.
(2)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. yoel@tropmedres.ac.
(3)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. stuart@tropmedres.ac.
(4)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. stuart@tropmedres.ac.
(5)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. susie@tropmedres.ac.
(6)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. susie@tropmedres.ac.
(7)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. ampai@tropmedres.ac.
(8)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. thomas.a@tropmedres.ac.
(9)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. wanitda@tropmedres.ac.
(10)shoklo malaria research unit (smru), mahidol-oxford tropical medicine
research unit, faculty tropical medicine, mahidol university, mae sot,
thailand. wanitda@tropmedres.ac.
(11)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. parigi@tropmedres.ac.
(12)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. parigi@tropmedres.ac.
(13)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. mayfong@tropmedres.ac.
(14)lao-oxford-mahosot hospital-wellcome trust research unit (lomwru), mahosot
hospital, vientiane, laos. mayfong@tropmedres.ac.
(15)faculty postgraduate studies, university health sciences, vientiane,
laos. mayfong@tropmedres.ac.
(16)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. tom@tropmedres.ac.
(17)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. tom@tropmedres.ac.
(18)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. arjen@tropmedres.ac.
(19)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. arjen@tropmedres.ac.
(20)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. nickwdt@tropmedres.ac.
(21)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. nickwdt@tropmedres.ac.
(22)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. nickd@tropmedres.ac.
(23)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. nickd@tropmedres.ac.
(24)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. francois@tropmedres.ac.
(25)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. francois@tropmedres.ac.
(26)shoklo malaria research unit (smru), mahidol-oxford tropical medicine
research unit, faculty tropical medicine, mahidol university, mae sot,
thailand. francois@tropmedres.ac.
(27)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. paul@tropmedres.ac.
(28)lao-oxford-mahosot hospital-wellcome trust research unit (lomwru), mahosot
hospital, vientiane, laos. paul@tropmedres.ac.
(29)mahidol-oxford tropical medicine research unit (moru), faculty tropical
medicine, mahidol university, bangkok, thailand. pault@tropmedres.ac.
(30)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. pault@tropmedres.ac.
(31)cambodia oxford medical research unit, angkor hospital children, siem
reap, cambodia. pault@tropmedres.ac.

background: poor targeting antimicrobial drugs contributes millions 
deaths year malaria, pneumonia, tropical infectious diseases.
while malaria rapid diagnostic tests improved use antimalarial drugs,
there similar tests guide use antibiotics undifferentiated
fevers. study estimate diagnostic accuracy two well established
biomarkers bacterial infection, procalcitonin c-reactive protein (crp) 
discriminating common viral bacterial infections malaria endemic
settings southeast asia.
methods: serum procalcitonin crp levels measured stored serum samples
from febrile patients enrolled three prospective studies conducted in
cambodia, laos and, thailand. 1372 patients microbiologically
confirmed diagnosis, 1105 single viral, bacterial malarial infection.
procalcitonin crp levels compared amongst aetiological groups 
their sensitivity specificity distinguishing bacterial infections and
bacteraemias viral infections estimated using standard thresholds.
results: serum concentrations biomarkers significantly higher in
bacterial infections malaria viral infections. auroc crp in
discriminating bacterial viral infections 0.83 (0.81-0.86)
compared 0.74 (0.71-0.77) procalcitonin (p < 0.0001). relative
advantage evident sites stratifying patients age and
admission status. crp threshold 10 mg/l, sensitivity detecting
bacterial infections 95% specificity 49%. threshold 20 mg/l
sensitivity 86% specificity 67%. procalcitonin low
threshold 0.1 ng/ml sensitivity 90% specificity 39%. a
higher threshold 0.5 ng/ul sensitivity 60% specificity 76%.
conclusion: samples febrile patients mono-infections rural
settings southeast asia, crp highly sensitive moderately specific
biomarker discriminating viral bacterial infections. use crp
rapid test peripheral health settings could potentially simple and
affordable measure better identify patients need antibacterial treatment
and part global strategy combat emergence antibiotic resistance.

doi: 10.1186/s12879-015-1272-6 
pmcid: pmc4642613
pmid: 26558692  [indexed medline]

